Publikasi Scopus 2010 s/d 2022

Jasim S.A., Yumashev A.V., Abdelbasset W.K., Margiana R., Markov A., Suksatan W., Pineda B., Thangavelu L., Ahmadi S.H.
57210594576;57189510951;57208873763;56685900600;57204626276;57219950613;6602946227;57221436939;57543981600;
Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases
2022
Stem Cell Research and Therapy
13
1
101
11
Medical Laboratory Techniques Department, Al-Maarif University College, Al-Anbar-Ramadi, Iraq; Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Moscow, Russian Federation; Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al Kharj, Saudi Arabia; Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt; Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Master’s Programme Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Dr. Soetomo General Academic Hospital, Surabaya, Indonesia; Tyumen State Medical University, Tyumen, Russian Federation; Industrial University, Tyumen, Russian Federation; Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand; Department of Neuroimmunology, National Institute of Neurology and Neurosurgery “Manuel Velasco Suarez” (INNN), 14269, Mexico City, Mexico; Center for Transdisciplinary Research ,Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai, India; Cellular and Molecular Research Center, School of Medicine, Tehran University of Medical Sciences, PO Box: 1417613151, Tehran, Iran
Jasim, S.A., Medical Laboratory Techniques Department, Al-Maarif University College, Al-Anbar-Ramadi, Iraq; Yumashev, A.V., Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Moscow, Russian Federation; Abdelbasset, W.K., Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al Kharj, Saudi Arabia, Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt; Margiana, R., Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Master’s Programme Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia; Markov, A., Tyumen State Medical University, Tyumen, Russian Federation, Industrial University, Tyumen, Russian Federation; Suksatan, W., Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand; Pineda, B., Department of Neuroimmunology, National Institute of Neurology and Neurosurgery “Manuel Velasco Suarez” (INNN), 14269, Mexico City, Mexico; Thangavelu, L., Center for Transdisciplinary Research ,Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai, India; Ahmadi, S.H., Cellular and Molecular Research Center, School of Medicine, Tehran University of Medical Sciences, PO Box: 1417613151, Tehran, Iran
The autoimmune diseases are associated with the host immune system, chronic inflammation, and immune reaction against self-antigens, which leads to the injury and failure of several tissues. The onset of autoimmune diseases is related to unbalanced immune homeostasis. Mesenchymal stem cells (MSCs) are multipotent cells which have capability to self-renew and differentiate into various cell types that exert a critical role in immunomodulation and regenerative therapy. Under the certain condition in vitro, MSCs are able to differentiate into multiple lineage such as osteoblasts, adipocytes, and neuron-like cells. Consequently, MSCs have a valuable application in cell treatment. Accordingly, in this review we present the last observations of researches on different MSCs and their efficiency and feasibility in the clinical treatment of several autoimmune disorders including rheumatoid arthritis, type 1 diabetes, multiple sclerosis, systemic lupus erythematosus, inflammatory bowel disease, autoimmune liver disease, and Sjogren’s syndrome. [Figure not available: see fulltext.]. © 2022, The Author(s).
Autoimmune diseases; Clinical application; Mesenchymal stromal cell; Stem cell therapy
alanine aminotransferase; alkaline phosphatase; aspartate aminotransferase; biological marker; C peptide; chemokine; corticosteroid derivative; cytokine; disease modifying antirheumatic drug; gamma glutamyltransferase; growth factor; hemoglobin A1c; immunoglobulin G; immunoglobulin M; methotrexate; nonsteroid antiinflammatory agent; placebo; adipose derived stem cell; allogeneic stem cell transplantation; antigen expression; autoimmune disease; autoimmune liver disease; autologous stem cell transplantation; bone marrow mesenchymal stem cell; bone marrow suppression; cell regeneration; cellular immunity; clinical effectiveness; cytokine production; digestive system injury; feasibility study; human; immunoregulation; inflammatory bowel disease; insulin dependent diabetes mellitus; liver inju
BioMed Central Ltd
17576512
35255979
Review
Q1
1330
2585